Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

SynCore Biotechnology Co., Ltd. (4192) Financial Statements

SynCore Biotechnology Co., Ltd. Financial Overview

SynCore Biotechnology Co., Ltd.'s market cap is currently NT$563.91M. The company's EPS TTM is NT$-1300.03; its P/E ratio is -0.01; SynCore Biotechnology Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Mar 24Dec 22Dec 21
Income Statement
Total RevenueNT$ 27.04MNT$ 23.34MNT$ 20.20MNT$ 15.86MNT$ 6.94M
Gross ProfitNT$ 21.09MNT$ 12.89MNT$ 521.00KNT$ 9.09MNT$ 2.97M
Operating IncomeNT$ -47.20MNT$ -57.76MNT$ -45.50MNT$ -186.40MNT$ -456.56M
EBITDANT$ -29.62MNT$ -35.80MNT$ -17.73MNT$ -146.32MNT$ -404.13M
Net IncomeNT$ -45.76MNT$ -54.28MNT$ -38.17MNT$ -188.67MNT$ -458.60M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 164.41MNT$ 212.44MNT$ 271.36MNT$ 275.81MNT$ 559.63M
Total AssetsNT$ 255.70MNT$ 317.80MNT$ 378.36MNT$ 436.65MNT$ 824.44M
Total DebtNT$ 2.10MNT$ 7.98MNT$ 2.11MNT$ 71.76MNT$ 125.46M
Net DebtNT$ -155.24MNT$ -197.50MNT$ -262.58MNT$ -197.39MNT$ -427.51M
Total LiabilitiesNT$ 10.07MNT$ 23.11MNT$ 21.23MNT$ 187.64MNT$ 381.52M
Stockholders' EquityNT$ 245.63MNT$ 294.69MNT$ 357.14MNT$ 249.01MNT$ 442.92M
Cash Flow
Free Cash FlowNT$ -38.74MNT$ -49.70MNT$ -83.13MNT$ -210.65MNT$ -231.50M
Operating Cash FlowNT$ -38.33MNT$ -49.24MNT$ -82.37MNT$ -209.61MNT$ -229.86M
Investing Cash FlowNT$ -252.00KNT$ -457.00KNT$ -778.00KNT$ -1.03MNT$ -1.64M
Financing Cash FlowNT$ -9.63MNT$ -9.51MNT$ 78.67MNT$ -73.21MNT$ 245.31M

Currency in TWD

SynCore Biotechnology Co., Ltd. Earnings and Revenue History

-500M-250M0250M-7500 %-5000 %-2500 %0 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

SynCore Biotechnology Co., Ltd. Liabilities to Assets

0400M800M1.2B0 %20 %40 %60 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

SynCore Biotechnology Co., Ltd. Cash Flow

-500M-250M0250M500M750M2019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

SynCore Biotechnology Co., Ltd. Forecast EPS vs Actual EPS

-0.4-0.4-0.3-0.3-0.2-0.2Q3 25Q4 25Q1 26Q2 26Q3 26EPS EstimateBeatMiss
Earnings >